Pharmaceuticals · Market research

Pulmonary Fibrosis Treatment reports

Coverage across 33 countries and regions. Researched figures and forecasts come with the full report.

Get the full Pulmonary Fibrosis Treatment market evidence

The purchased report supplies researched market size, forecast, growth, segments, competition and sources.

Buy the full report Request free sample
Pulmonary Fibrosis Treatment reports by place
PlaceCurrent sizeForecastGrowthActive trialsReport
WorldIn full reportIn full reportIn full report445View report
AfricaIn full reportIn full reportIn full report14View report
APACIn full reportIn full reportIn full report89View report
AustraliaIn full reportIn full reportIn full report32View report
BrazilIn full reportIn full reportIn full report7View report
CanadaIn full reportIn full reportIn full report43View report
ChinaIn full reportIn full reportIn full report47View report
EcuadorIn full reportIn full reportIn full report0View report
EgyptIn full reportIn full reportIn full report8View report
EuropeIn full reportIn full reportIn full report133View report
FranceIn full reportIn full reportIn full report57View report
GermanyIn full reportIn full reportIn full report41View report
Hong KongIn full reportIn full reportIn full report0View report
IndiaIn full reportIn full reportIn full report8View report
ItalyIn full reportIn full reportIn full report51View report
JapanIn full reportIn full reportIn full report14View report
KenyaIn full reportIn full reportIn full report0View report
Latin AmericaIn full reportIn full reportIn full report14View report
MalaysiaIn full reportIn full reportIn full report4View report
MexicoIn full reportIn full reportIn full report12View report
Middle EastIn full reportIn full reportIn full report1View report
New ZealandIn full reportIn full reportIn full report12View report
North AmericaIn full reportIn full reportIn full report202View report
PhilippinesIn full reportIn full reportIn full report1View report
RussiaIn full reportIn full reportIn full report1View report
Saudi ArabiaIn full reportIn full reportIn full report1View report
SingaporeIn full reportIn full reportIn full report2View report
South AfricaIn full reportIn full reportIn full report4View report
SpainIn full reportIn full reportIn full report35View report
ThailandIn full reportIn full reportIn full report2View report
UAEIn full reportIn full reportIn full report0View report
UKIn full reportIn full reportIn full report58View report
USIn full reportIn full reportIn full report182View report

Public clinical research

445 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

  1. Enhanced Pulmonary Fibrosis Treatment by Self-Assembling Peptide Nanofibers via Improved Pulmonary Delivery and Retention.Journal of medicinal chemistry, 2026
  2. A Phase I Study Assessing the Safety, Tolerability, and Pharmacokinetics of Yinfenidone: A Novel, Potent Drug for Idiopathic Pulmonary Fibrosis Treatment in Healthy Chinese Subjects.Clinical therapeutics, 2026
  3. Global landscape for pulmonary fibrosis treatment: a data-driven perspective from clinical trials.BMC pulmonary medicine, 2026
  4. Marine-derived surfactin derivatives suppress collagen production and interfere with the HSP47-collagen interaction in preclinical models.Frontiers in pharmacology, 2026
  5. Inhalable disulfiram pure-drug nanoparticles stabilized by phospholipid/TPSS for effective pulmonary fibrosis treatment in mice.International journal of pharmaceutics, 2026

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.